To further investigate whether FGD3 mRNA expression is a feature of the tumor, breast cancer TMAs were purchased from US Biomax, and IHC was used to determine FGD3 protein expression levels (scored from 0 to 4). This evidence concerns the gene FGD3 and breast carcinoma.